Disfunción neurocognitiva en niños con leucemia linfoide aguda

Martínez-Triana, Raúl; Guerra-González, Eva María; González-Otero, Alejandro.
Rev. cuba. hematol. inmunol. hemoter ; 29(1): 73-81, ene.-mar. 2013.
Artigo em Espanhol | LILACS | ID: lil-666714

Documentos relacionados

  1. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
  2. Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia.
  3. Post-PICU Cognitive and Psychological Outcomes in Children Receiving Treatments for Acute Lymphoblastic Leukemia.
  4. Chemotherapy-related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia.
  5. Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia.
  6. Addisonian pigmentation associated with acute lymphoblastic leukemia: A rare paraneoplastic phenomenon.
  7. Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case study.
  8. Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment.
  9. High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study.
  10. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.